Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma ; volume:8 ; number:1 ; day:4 ; month:11 ; year:2020 ; pages:1-10 ; date:12.2020
Acta Neuropathologica Communications ; 8, Heft 1 (4.11.2020), 1-10, 12.2020

Creator: Fontanilles, Maxime
Marguet, Florent
Beaussire, Ludivine
Magne, Nicolas
Pépin, Louis-Ferdinand
Alexandru, Cristina
Tennevet, Isabelle
Hanzen, Chantal
Langlois, Olivier
Jardin, Fabrice
Laquerrière, Annie
Sarafan-Vasseur, Nasrin
Fiore, Fréderic Di
Clatot, Florian

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-020-01057-7

URN: urn:nbn:de:101:1-2020121719131858021299

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Fontanilles, Maxime
Marguet, Florent
Beaussire, Ludivine
Magne, Nicolas
Pépin, Louis-Ferdinand
Alexandru, Cristina
Tennevet, Isabelle
Hanzen, Chantal
Langlois, Olivier
Jardin, Fabrice
Laquerrière, Annie
Sarafan-Vasseur, Nasrin
Fiore, Fréderic Di
Clatot, Florian
SpringerLink (Online service)

Other Objects (12)

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

Frequency of TERT Promoter Mutations in Prostate Cancer

Hochschulschrift

hTERT Promoter-Mutationen in humanen Tumoren der Leber

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Interstitial photodynamic therapy for newly diagnosed glioblastoma

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers

Human TERT promoter mutations as a prognostic biomarker in glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

Frequency of TERT Promoter Mutations in Prostate Cancer

Hochschulschrift

hTERT Promoter-Mutationen in humanen Tumoren der Leber

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Interstitial photodynamic therapy for newly diagnosed glioblastoma

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers

Human TERT promoter mutations as a prognostic biomarker in glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

Frequency of TERT Promoter Mutations in Prostate Cancer

Hochschulschrift

hTERT Promoter-Mutationen in humanen Tumoren der Leber

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Interstitial photodynamic therapy for newly diagnosed glioblastoma

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers

Human TERT promoter mutations as a prognostic biomarker in glioma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

Frequency of TERT Promoter Mutations in Prostate Cancer

hTERT Promoter-Mutationen in humanen Tumoren der Leber

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Interstitial photodynamic therapy for newly diagnosed glioblastoma

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers

Human TERT promoter mutations as a prognostic biomarker in glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

Frequency of TERT Promoter Mutations in Prostate Cancer

hTERT Promoter-Mutationen in humanen Tumoren der Leber

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Interstitial photodynamic therapy for newly diagnosed glioblastoma

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers

Human TERT promoter mutations as a prognostic biomarker in glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

Frequency of TERT Promoter Mutations in Prostate Cancer

hTERT Promoter-Mutationen in humanen Tumoren der Leber

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Interstitial photodynamic therapy for newly diagnosed glioblastoma

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers

Human TERT promoter mutations as a prognostic biomarker in glioma

Related objects

Reset password